Otsuka Pakistan Company Description
Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.
The company’s products include electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products, such as aminoleban oral, proten gold, pan-amin G, aminoleban injection, and aminovel 600; and therapeutic drugs, which include mucosta tablets and pletaal, as well as oral rehydration therapy.
It also engages in the trading of pharmaceutical products, nutritional foods, and medical equipment. Further, the company offers Made in Germany CE-marked drug-eluting coronary stents, PTCA balloon catheters, and other coronary angioplasty accessories and electrophysiology products.
The company was incorporated in 1988 and is headquartered in Karachi, Pakistan.
Country | Pakistan |
Founded | 1988 |
Industry | Pharmaceuticals |
Sector | Healthcare |
Employees | 362 |
CEO | Moin-ur Rehman |
Contact Details
Address: 30-B, Sindhi Muslim Co-operative Housing Society Karachi, 74400 Pakistan | |
Phone | 92 21 3452 8651 |
Website | otsuka.pk |
Stock Details
Ticker Symbol | OTSU |
Exchange | Pakistan Stock Exchange |
Fiscal Year | July - June |
Reporting Currency | PKR |
ISIN Number | PK0038001019 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Moin-ur Rehman | Chief Executive Officer |
Rao Sajid Khan | Chief Financial Officer |